A Personal Reflection of Greenlight 532 nm Laser for BPH Treatment

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia are a bothersome symptom set that affect approximately one in every four males above the age of 50. First line treatment is typically medication, but when medications fail surgical therapy is the next option. Technological advances have made surgical therapy safer and more effective. One area that our group has particular interest and focus in is the application of the 532 nm laser in surgical therapy. The high power 532 nm laser is used to remove obstructive prostatic tissue and the laser energy is selectively absorbed by hemoglobin in the prostate tissue, resulting in effective tissue vaporization and removal. We review our experience with Greenlight laser system and its evolution from the original 60-watt laser to the most recent 180-watt Greenlight system with MoXy fiber.

Download Full-text

Saw Palmetto and Benign Prostatic Hyperplasia

The American Journal of Chinese Medicine ◽

10.1142/s0192415x04001989 ◽

2004 ◽

Vol 32 (03) ◽

pp. 331-338 ◽

Cited By ~ 11

Author(s):

Edward M. Gong ◽

Glenn S. Gerber

Keyword(s):

Urinary Tract ◽

Benign Prostatic Hyperplasia ◽

Prostatic Hyperplasia ◽

Placebo Effects ◽

Urinary Function ◽

First Line ◽

Saw Palmetto ◽

Urinary Tract Symptoms ◽

Lower Urinary

Benign prostatic hyperplasia (BPH) is a common health issue that affects 8% of all men at the age of 40, 60% of men in their 70s, and 90% of those greater than 80 years of age. One-fourth of these men will develop moderate to severe lower urinary tract symptoms that greatly affect their quality of life. Recent evidence suggests that the use of saw palmetto leads to improvements in urinary function for those suffering from BPH. The favorable comparison of saw palmetto with tamsulosin, a well-known first line agent in the treatment of urinary tract symptoms, demonstrates promise towards a beneficial effect of this herbal agent, with very few, if any, adverse effects. However, what degree of this beneficial activity is due to placebo effects is yet to be determined. In addition, the precise mechanism of action of saw palmetto in men with BPH remains unclear.

Download Full-text

Non-uroselective and uroselective α1-adrenolitics in everyday urological practice – the duel

Medycyna Faktów ◽

10.24292/01.mf.0320.1 ◽

2020 ◽

Vol 13 (3) ◽

pp. 275-278

Author(s):

Kajetan Juszczak ◽

Tomasz Drewa

Keyword(s):

Benign Prostatic Hyperplasia ◽

Lower Urinary Tract ◽

Low Frequency ◽

Prostatic Hyperplasia ◽

First Line ◽

Onset Of Action ◽

Specific Patient ◽

Urinary Tract Symptoms ◽

First Line Treatment ◽

Lower Urinary

α1-adrenolitics are often considered the first-line treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) due to their quick onset of action, good efficacy and low frequency and severity of side effects. α1-adrenolitics are divided into non-uroselective and uroselective. The study compared two drugs, such as doxazosin and tamsulosin. The presented duel and its result may help in choosing the best treatment option for a specific patient with benign prostatic hyperplasia.

Download Full-text